
Chemical and Pharmaceutical Bulletin p. 1532 - 1537 (1999)
Update date:2022-07-31
Topics:
Akasaka, Kozo
Komatsu, Yuki
Tagami, Katsuya
Shimizu, Toshikazu
Shimomura, Naoyuki
Naka, Hiroshi
Hayashi, Kenji
Negi, Shigeto
An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)- Methyl-6-oxopipecolic acid ester (3a), prepared from L-α,-aminoadipic acid, was chemoselectively reduced to the
View MoreTaizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Nanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
website:http://www.lonwinchem.com
Contact:Tel: 86-21-59858395
Address:No#966,Huaxu Road,Shanghai 201702,P.R.China
Jinzhou Jiutai Pharmaceutical Co.,Ltd
Contact:+86-0416-5179890
Address:No.41, Taianli, Taihe District, Jinzhou, Liaoning
Hunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Doi:10.1016/j.molstruc.2012.12.018
(2013)Doi:10.3109/14756366.2011.653355
(2013)Doi:10.1039/c3ra41640b
(2013)Doi:10.1021/ol400493x
(2013)Doi:10.1016/j.jorganchem.2013.01.013
(2013)Doi:10.1021/om400025h
(2013)